We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · October 04, 2019

Potential Impact of Low-Dose Methotrexate on Symptoms Associated With Myeloproliferative Neoplasms

British Journal of Haematology

 

Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Haematology
Low-Dose Methotrexate: Potential Clinical Impact on Haematological and Constitutional Symptoms in Myeloproliferative Neoplasms
Br. J. Haematol 2019 Sep 16;[EPub Ahead of Print], S Francis, S Thomas, R Luben, N Sousos, A Mead, JA Snowden, MP Zeidler

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading